BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 708016)

  • 1. Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
    Zlitni S; Bishara A; Moss EL; Tkachenko E; Kang JB; Culver RN; Andermann TM; Weng Z; Wood C; Handy C; Ji HP; Batzoglou S; Bhatt AS
    Genome Med; 2020 May; 12(1):50. PubMed ID: 32471482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus.
    Zhao J; Cheah SE; Roberts KD; Nation RL; Thompson PE; Velkov T; Du Z; Johnson MD; Li J
    mSphere; 2016; 1(4):. PubMed ID: 27471750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and Dissipation of the Antibiotics Sulfamethoxazole, Sulfadiazine, Trimethoprim, and Enrofloxacin in the Mekong Delta, Vietnam.
    Nguyen Dang Giang C; Sebesvari Z; Renaud F; Rosendahl I; Hoang Minh Q; Amelung W
    PLoS One; 2015; 10(7):e0131855. PubMed ID: 26135396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of Faecalibacterium prausnitzii from calves and piglets.
    Foditsch C; Santos TM; Teixeira AG; Pereira RV; Dias JM; Gaeta N; Bicalho RC
    PLoS One; 2014; 9(12):e116465. PubMed ID: 25551453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of microarray and functional-based screening methods for the detection of antimicrobial resistance genes in the microbiomes of healthy humans.
    Card RM; Warburton PJ; MacLaren N; Mullany P; Allan E; Anjum MF
    PLoS One; 2014; 9(1):e86428. PubMed ID: 24466089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
    Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.
    Swenson JM; Thornsberry C; McCroskey LM; Hatheway CL; Dowell VR
    Antimicrob Agents Chemother; 1980 Jul; 18(1):13-9. PubMed ID: 6998374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of brodimoprim and metioprim alone and in combination with sulfonamides against anaerobic bacteria.
    Wüst J; Schwarzenbach J
    Antimicrob Agents Chemother; 1983 Mar; 23(3):490-2. PubMed ID: 6847174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
    Wormser GP; Keusch GT; Heel RC
    Drugs; 1982 Dec; 24(6):459-518. PubMed ID: 6759092
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of anaerobic infections.
    Wilkins TD; West SE
    Infection; 1983; 11 Suppl 2():S105-8. PubMed ID: 6671796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance of anaerobic bacteria (author's transl)].
    Niederau W; Höffler U; Pulverer G
    Infection; 1982; 10(3):177-83. PubMed ID: 6286503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1979 Jan; 15(1):1-6. PubMed ID: 218496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.
    Wüst J; Wilkins TD
    Antimicrob Agents Chemother; 1978 Sep; 14(3):384-90. PubMed ID: 708016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of anaerobes to co-trimoxazole.
    Wüst J
    Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique.
    Riley TV
    Antimicrob Agents Chemother; 1981 Dec; 20(6):731-5. PubMed ID: 7325639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.